Ultrasound | CHOP Research Institute


Published on
Feb 6, 2023
Two scientists with unique skill sets are developing an alternative method for gene therapy delivery with support from a CGTC Seed Grant.

In this study, we are developing new ultrasound and magnetic resonance imaging (MRI) methods to measure kidney and liver disease severity in autosomal recessive polycystic kidney disease (ARPKD).

You are invited to take part in a voluntary research trial because you have a genetic defect in vitamin D metabolism that causes elevated blood and/or urine levels of calcium and you are between the ages of 6 months and 65 years.

Research in the Hartung Lab focuses on genetic kidney diseases, particularly autosomal recessive polycystic kidney disease (ARPKD).

When you’re in need of radiological imaging for your research, look no further than the Small Animal Imaging Facility at Children’s Hospital.

Dr. Hartung's clinical and translational research program focuses on autosomal recessive polycystic kidney disease and other genetic kidney diseases, development of new kidney and liver imaging biomarkers, and neurocognitive outcomes in children with chronic kidney disease.

hartunge [at] chop.edu
Published on
Sep 15, 2015
Children’s hospitals are shifting away from imaging techniques that use ionizing radiation and moving toward alternatives that do not pose potential hazards.
Published on
Oct 27, 2014
Kidney specialists across the country agree that the incidence of kidney stones is rising among children, but clinicians are unsettled on which imaging technology to choose first when diagnosing the condition, despite current guidelines that recommend ultrasound as the initial imaging study.